Skip to main content

Loading market ticker...

Why Is NGL Fine-Chem (NSE: NGLFINE) Rebounding Sharply After the Recent Sell-Off?

Why Is NGL Fine-Chem (NSE: NGLFINE) Rebounding Sharply After the Recent Sell-Off?

Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Highlights

  • NGL Fine-Chem is witnessing a sharp recovery during Tuesday’s trading session after recent price volatility.
  • The company reported total income of ₹14,406.99 lakh and net profit of ₹1,645.13 lakh for June 2026.
  • The stock was trading at ₹3,236.80, compared with the previous close of ₹2,908.40.
  • The price has moved back above the 50-day SMA of ₹3,161.35, changing the immediate technical structure.
  • Trading activity has increased, with volume of 54.08K shares and VWAP at ₹3,194.56.
  • Investors should monitor whether the recovery holds, along with volume behaviour, momentum and upcoming business developments.

Overview

NGL Fine-Chem Limited (NSE: NGLFINE) is engaged in the manufacturing and supply of pharmaceutical and veterinary products, with its business serving healthcare-related markets. On August 18, 2026, the stock was trading at ₹3,236.80, up 11.36% from the previous close of ₹2,908.40. It opened at ₹2,940.00, touched a high of ₹3,265.00 and a low of ₹2,923.20, while VWAP stood at ₹3,194.56. The move follows a sharp recent correction visible on the daily chart, during which the stock briefly moved below its recent trading range before recovering. The latest session has therefore attracted attention as the price returns above its 50-day moving average.

Fundamental View

For the quarter ended June 30, 2026, NGL Fine-Chem reported standalone total income of ₹14,406.99 lakh, profit before tax of ₹2,174.51 lakh and net profit of ₹1,645.13 lakh. Earnings per share stood at ₹26.63. The reported figures indicate positive profitability during the quarter, although investors will need to track subsequent revenue growth, operating margins, costs and earnings consistency to assess the direction of the business. The company's future financial performance, demand conditions across its served markets and changes in operating expenses remain relevant monitoring points. The latest quarterly figures are more than three days old and therefore are not being treated as the immediate reason for Tuesday's price movement.

Technical View

The daily chart shows a longer-term upward price structure, although the stock experienced a sharp recent correction before recovering in the latest session. The current price of ₹3,236.80 is above the 50-day SMA of ₹3,161.35, restoring a key reference level after the recent weakness. RSI has recovered to 49.43 after falling sharply during the previous session, while its signal average is at 59.33. This indicates that the immediate momentum has improved from the recent low, but the RSI remains below the midpoint of the conventional range. Volume of 54.08K shares accompanies the latest move, while the price is also trading above VWAP, indicating stronger session-level price positioning.

Key Technical Levels

Support is visible around ₹3,075, followed by the next support zone near ₹2,913. Resistance can be observed around ₹3,398, while the next resistance zone is near ₹3,560. The 50-day SMA at ₹3,161.35 also remains an important technical reference, as the stock is currently positioned above this average.

Risks to Watch

  • Recent price volatility could lead to further wide daily trading ranges.
  • A sustained move below the 50-day SMA could weaken the current recovery structure.
  • RSI remains below the midpoint despite the latest price rebound.
  • Changes in pharmaceutical and veterinary product demand could affect future revenue.
  • Quarterly margins, costs and earnings consistency require continued monitoring.

Summary

NGL Fine-Chem Limited has staged a sharp recovery after the recent sell-off, with the stock trading at ₹3,236.80 and moving back above its 50-day SMA of ₹3,161.35. The June 2026 quarter showed total income of ₹14,406.99 lakh and net profit of ₹1,645.13 lakh, providing a profitable recent financial backdrop, although those results are not the immediate headline driver because they are more than three days old. Technically, the latest move has improved the short-term price structure, while RSI and trading activity require further observation. Future monitoring will centre on price stability, volumes, earnings performance, margins and business developments.

FAQs

Q: Why is NGL Fine-Chem rebounding sharply after the recent sell-off?

A: The stock is showing a strong recovery after recent price weakness, with Tuesday’s session placing the price back above its 50-day SMA.

Q: What is NGL Fine-Chem’s current 50-day SMA?

A: The 50-day SMA shown on the daily chart is ₹3,161.35.

Q: What was NGL Fine-Chem’s net profit in the June 2026 quarter?

A: The company reported a net profit of ₹1,645.13 lakh for the quarter ended June 30, 2026.

Q: What is NGL Fine-Chem’s current RSI?

A: The 14-day RSI shown on the chart is 49.43, after recovering from the sharp decline recorded during the previous session.

Q: What technical levels should be monitored for NGL Fine-Chem?

A: Support can be monitored around ₹3,075 and ₹2,913, while resistance can be observed around ₹3,398 and ₹3,560.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.